<DOC>
	<DOCNO>NCT00154492</DOCNO>
	<brief_summary>This trial conduct Asia Europe . The trial plan investigate effectiveness safety NovoSeven® patient advance cirrhosis active variceal bleeding .</brief_summary>
	<brief_title>Use NovoSeven® Active Variceal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Variceal bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Active variceal bleeding patient advance cirrhosis</keyword>
</DOC>